268 related articles for article (PubMed ID: 29765236)
1. Methicillin-resistant
Liu T; Zhang Y; Wan Q
Infect Drug Resist; 2018; 11():647-658. PubMed ID: 29765236
[TBL] [Abstract][Full Text] [Related]
2. Impact of Molecular Epidemiology and Reduced Susceptibility to Glycopeptides and Daptomycin on Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia.
Lee HY; Chen CL; Liu SY; Yan YS; Chang CJ; Chiu CH
PLoS One; 2015; 10(8):e0136171. PubMed ID: 26295150
[TBL] [Abstract][Full Text] [Related]
3. Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study.
Shorr AF; Zilberberg MD; Micek ST; Kollef MH
Crit Care; 2015 Sep; 19(1):312. PubMed ID: 26335247
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.
Li Z; Zhuang H; Wang G; Wang H; Dong Y
BMC Infect Dis; 2021 Jan; 21(1):74. PubMed ID: 33446122
[TBL] [Abstract][Full Text] [Related]
5. Morbidity, mortality, and management of methicillin-resistant S. aureus bacteremia in the USA: update on antibacterial choices and understanding.
Ortwine JK; Bhavan K
Hosp Pract (1995); 2018 Apr; 46(2):64-72. PubMed ID: 29400119
[TBL] [Abstract][Full Text] [Related]
6. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
[TBL] [Abstract][Full Text] [Related]
7. Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment.
Hassoun A; Linden PK; Friedman B
Crit Care; 2017 Aug; 21(1):211. PubMed ID: 28807042
[TBL] [Abstract][Full Text] [Related]
8. Bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: the potential role of daptomycin.
Bamberger DM
Ther Clin Risk Manag; 2007 Aug; 3(4):675-84. PubMed ID: 18472990
[TBL] [Abstract][Full Text] [Related]
9. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP) Bloodstream Infection Annual Report 2022.
Coombs GW; Daley DA; Shoby P; Mowlaboccus S
Commun Dis Intell (2018); 2023 Nov; 47():. PubMed ID: 37968066
[TBL] [Abstract][Full Text] [Related]
10. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort Study.
Wang JT; Hsu LY; Lauderdale TL; Fan WC; Wang FD
PLoS One; 2015; 10(12):e0144710. PubMed ID: 26690351
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia.
Abraham J; Mansour C; Veledar E; Khan B; Lerakis S
Am Heart J; 2004 Mar; 147(3):536-9. PubMed ID: 14999206
[TBL] [Abstract][Full Text] [Related]
13. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
Coombs GW; Daley DA; Lee YT; Pang S
Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in liver transplant recipients.
Kim YJ; Kim SI; Choi JY; Yoon SK; You YK; Kim DG
Korean J Intern Med; 2015 Sep; 30(5):694-704. PubMed ID: 26354064
[TBL] [Abstract][Full Text] [Related]
15. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.
Roghmann MC
Arch Intern Med; 2000 Apr; 160(7):1001-4. PubMed ID: 10761966
[TBL] [Abstract][Full Text] [Related]
16. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
17. Methicillin-resistant Staphylococcus aureus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Pereira MR; Rana MM;
Clin Transplant; 2019 Sep; 33(9):e13611. PubMed ID: 31120612
[TBL] [Abstract][Full Text] [Related]
18. Clinical management of Staphylococcus aureus bacteremia: a review.
Holland TL; Arnold C; Fowler VG
JAMA; 2014 Oct; 312(13):1330-41. PubMed ID: 25268440
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus nasal colonization and association with infections in liver transplant recipients.
Chang FY; Singh N; Gayowski T; Drenning SD; Wagener MM; Marino IR
Transplantation; 1998 May; 65(9):1169-72. PubMed ID: 9603162
[TBL] [Abstract][Full Text] [Related]
20. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP).
Coombs GW; Daley DA; Shoby P; Mowlaboccus S
Commun Dis Intell (2018); 2022 Dec; 46():. PubMed ID: 36529133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
